Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications.
Cholangiocarcinoma (CCA) is clinically heterogeneous; intra and extrahepatic CCA have diverse clinical presentations. Next generation sequencing (NGS) technology may identify the genetic differences between these entities and identify molecular subgroups for targeted therapeutics.We describe success...
Main Authors: | Chaitanya R Churi, Rachna Shroff, Ying Wang, Asif Rashid, HyunSeon C Kang, Jacqueline Weatherly, Mingxin Zuo, Ralph Zinner, David Hong, Funda Meric-Bernstam, Filip Janku, Christopher H Crane, Lopa Mishra, Jean-Nicholas Vauthey, Robert A Wolff, Gordon Mills, Milind Javle |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4275227?pdf=render |
Similar Items
-
Whole Genome Sequencing in Cancer Clinics
by: Ken Chen, et al.
Published: (2015-01-01) -
The rapamycin-regulated gene expression signature determines prognosis for breast cancer
by: Tsavachidis Spiridon, et al.
Published: (2009-09-01) -
Updates in Gastrointestinal Oncology – insights from the 2008 44<sup>th </sup>annual meeting of the American Society of Clinical Oncology
by: Hsueh Chung-Tsen, et al.
Published: (2009-02-01) -
Recent advances in gastrointestinal oncology - updates and insights from the 2009 annual meeting of the American Society of Clinical Oncology
by: Hsueh Chung-Tsen, et al.
Published: (2010-03-01) -
CanDrA: cancer-specific driver missense mutation annotation with optimized features.
by: Yong Mao, et al.
Published: (2013-01-01)